E-LIB Suche - Ergebnisse für: Schlam, Ilana

1

Advancing equitable and personalized cancer care: Novel app..:

Cobanaj, Marisa ; Corti, Chiara ; Dee, Edward C....
European Journal of Cancer. 198 (2024) - p. 113504 , 2024

Link: https://doi.org/10.1016/..

2

Author Correction: Adjuvant nivolumab, capecitabine or the ..:

Lynce, Filipa ; Mainor, Candace ; Donahue, Renee N....
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

3

Immunotherapy for Early-Stage Triple Negative Breast Cancer..:

Song, Fei ; Tarantino, Paolo ; Garrido-Castro, Ana...
Current Oncology Reports. 26 (2024) 1 - p. 21-33 , 2024

Link: https://doi.org/10.1007/..

4

Best of the year: Advanced breast cancer in 2023:

Schlam, Ilana ; Chavez-MacGregor, Mariana
The Breast. 74 (2024) - p. 103677 , 2024

Link: https://doi.org/10.1016/..

5

Dexrazoxane to Prevent Cardiotoxicity in Adults Treated wit..:

Upshaw, Jenica N. ; Parson, Susan K. ; Buchsbaum, Rachel J....
JACC: CardioOncology. 6 (2024) 2 - p. 322-324 , 2024

Link: https://doi.org/10.1016/..

6

Adjuvant nivolumab, capecitabine or the combination in pati..:

Lynce, Filipa ; Mainor, Candace ; Donahue, Renee N....
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

7

Addressing Residual Disease in HER2-Positive and Triple-Neg..:

Schlam, Ilana ; Dower, Joshua ; Lynce, Filipa
Current Oncology Reports. , 2024

Link: https://doi.org/10.1007/..

8

Potential and Pitfalls of Pharmacovigilance Databases in On..:

Schlam, Ilana ; Ewer, Michael S. ; Swain, Sandra M.
JACC: CardioOncology. 5 (2023) 1 - p. 99-101 , 2023

Link: https://doi.org/10.1016/..

9

Next-generation antibody-drug conjugates for breast cancer:..:

Schlam, Ilana ; Moges, Ruth ; Morganti, Stefania..
Critical Reviews in Oncology/Hematology. 190 (2023) - p. 104090 , 2023

Link: https://doi.org/10.1016/..

10

Filling the Gap after CDK4/6 Inhibitors: Novel Endocrine an..:

Mittal, Abhenil ; Molto Valiente, Consolacion ; Tamimi, Faris...
Cancers. 15 (2023) 7 - p. 2015 , 2023

Link: https://doi.org/10.3390/..

11

Tailoring the Treatment of Early-stage HER2-positive Breast..:

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA ; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy...
Oncology & Haematology. 19 (2023) 1 - p. 11 , 2023

Link: https://doi.org/10.17925..

12

How I treat HER2-low advanced breast cancer:

Schlam, Ilana ; Tolaney, Sara M. ; Tarantino, Paolo
The Breast. 67 (2023) - p. 116-123 , 2023

Link: https://doi.org/10.1016/..

13

Opportunities and Challenges for a Histology-Agnostic Utili..:

Neupane, Niraj ; Thapa, Sangharsha ; Bhattarai, Abhinav...
Current Oncology Reports. , 2023

Link: https://doi.org/10.1007/..

14

Emerging Targeted Therapies for Early Breast Cancer:

Schlam, Ilana ; Tarantino, Paolo ; Morganti, Stefania...
Drugs. 82 (2022) 14 - p. 1437-1451 , 2022

Link: https://doi.org/10.1007/..

15

Profile of Margetuximab: Evidence to Date in the Targeted T..:

Schlam, Ilana ; Nunes, Raquel ; Lynce, Filipa
OncoTargets and Therapy. 15 (2022) - p. 471-478 , 2022

Link: https://doi.org/10.2147/..